UBS lowers McGraw Hill price target to $14
UBS analyst Joshua Chan maintains a Neutral rating on McGraw Hill but lowers the price target from $17 to $14, signaling a revised valuation outlook.
*this image is generated using AI for illustrative purposes only.
UBS analyst Joshua Chan has maintained a Neutral rating on McGraw Hill while lowering the price target to $14 from $17. The revised target indicates a more cautious near-term outlook for the company's stock performance.
Rating and Price Action
The research note from UBS highlights a shift in valuation expectations for McGraw Hill. Despite maintaining a Neutral stance, the reduction in the price target suggests potential headwinds or a recalibration of growth projections.
| Metric | Previous | Revised |
|---|---|---|
| Rating | Neutral | Neutral |
| Price Target | $17 | $14 |
What specific headwinds prompted UBS to lower the price target for McGraw Hill?
How might this revised outlook impact investor sentiment toward McGraw Hill in the near term?
Could other analysts follow UBS in adjusting their price targets for the company?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
